Company Name or Ticker Symbol
Search for other Categories

Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period

ATRA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth

ATRA Quick Ratio for Trailing Twelve Months Period

(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Current Liabilities Growth -12.14 % 40.45 % 79.19 % 88.51 % 144.34 %
Y / Y Cash & cash equivalent Growth 86.42 % 81.99 % 92.18 % 76.54 % -35.04 %
Quick Ratio for Trailing Twelve Months Period 18.92 16.51 15.79 14.94 13.7
Total Ranking # 169 # 166 # 161 # 160 # 159
Seq. Current Liabilities Growth -10.47 % 12.75 % 39.83 % -37.76 % 43.13 %
Seq. Cash & cash equivalent Growth -15.11 % -12.58 % 2.38 % 145.35 % -17.12 %

Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Atara Biotherapeutics, Inc. Cash & cash equivalent average soared by 86.42 % in IV. Quarter year on year, while Current Liabilities fell to $21 millions, this led to increase in in Atara Biotherapeutics's Quick Ratio for Trailing Twelve Months Period to 18.92, Quick Ratio for Trailing Twelve Months Period remained below Atara Biotherapeutics, Inc. average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Drugs industry 20 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Atara Biotherapeutics. While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 166 to 169.

What is Quick Ratio?
Learn more about ATRA
Quick Ratio ATRA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 21
Sector # 63
S&P 500 # 164

Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
35.85 23.59 12.84
(June 30. 2016)   (Dec 31 2017)

Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2018, within Biotechnology & Drugs Industry Quick Ratio for Trailing Twelve Months Period
Krystal Biotech, Inc.  49.57 
Nightstar Therapeutics Plc  37.07 
Renovacare, Inc.  28.97 
Neuralstem, Inc.  25.01 
Rocket Pharmaceuticals, Inc.  24.57 
Aravive, Inc.  23.61 
Catalyst Biosciences, Inc.  21.54 
Regenxbio Inc.  21.18 
G1 Therapeutics, Inc.  21.06 
Iovance Biotherapeutics, Inc.  21.04 
Microbot Medical Inc.  20.38 
Acceleron Pharma Inc  18.46 
Evelo Biosciences, Inc.  18.33 
Eyenovia, Inc.  18.20 
Arcus Biosciences, Inc.  17.43 
Crispr Therapeutics Ag  17.15 
Fennec Pharmaceuticals Inc.  15.66 
Casi Pharmaceuticals, Inc.  15.63 
Scpharmaceuticals Inc.  15.53 
Voyager Therapeutics, Inc.  15.30 
Atara Biotherapeutics, Inc.  15.16 
Audentes Therapeutics, Inc.  15.01 
Denali Therapeutics Inc.  14.87 
Enzon Pharmaceuticals, Inc.  14.14 
Unity Biotechnology, Inc.  14.09 
Allena Pharmaceuticals, Inc.  14.02 
Pulse Biosciences, Inc.  14.00 
Solid Biosciences Inc.  13.62 
Nexien Biopharma, Inc.  13.54 
Iterum Therapeutics Plc  13.46 


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

SKT's Profile

Stock Price

SKT's Financials

Business Description


Charts & Quotes

SKT's News


SKT's Competitors

Customers & Markets

Economic Indicators

SKT's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071